Metraipolis › archive › dc_0da5b4804cbd

Regorafenib treatment for advanced, refractory gastrointestinal stromal tumor: a report of the UK managed access program — Europe PMC PMID:25905001

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/25905001
DOI
10.1186/2045-3329-4-17
License (as archived)
solo-consultazione
Archived
2026-10-08T12:27:00.643Z
SHA-256 of the archived text
d6e4df405722d28f7f327cb9ada3f0ee891cec3d1b97ea0470266895f90ec03e
Stable URL of this page
https://metraipolis.com/documento/dc_0da5b4804cbd

How to cite

Regorafenib treatment for advanced, refractory gastrointestinal stromal tumor: a report of the UK managed access program — Europe PMC PMID:25905001 — Europe PMC (en), https://europepmc.org/article/MED/25905001 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_0da5b4804cbd (Metraipolis archive dc_0da5b4804cbd, sha256 d6e4df405722d28f7f327cb9ada3f0ee891cec3d1b97ea0470266895f90ec03e)
BibTeX
@misc{dc0da5b4804cbd,
  title = {Regorafenib treatment for advanced, refractory gastrointestinal stromal tumor: a report of the UK managed access program — Europe PMC PMID:25905001},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/25905001},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_0da5b4804cbd; sha256 d6e4df405722d28f7f327cb9ada3f0ee891cec3d1b97ea0470266895f90ec03e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/25905001. Agents can read the archived copy with the MCP tool read_document.